Aclaris Therapeutics (ACRS) Net Margin Growth (3y) (2020 - 2026)
Aclaris Therapeutics (ACRS) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Aclaris Therapeutics |
580.93 Mn |
580.93 Mn |
1.60 Mn |
14,749.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
14,749.00 |
| Dec 31, 2025 |
-125,428.00 |
| Sep 30, 2025 |
-35,493.00 |
| Jun 30, 2025 |
45,161.00 |
| Mar 31, 2025 |
20,722.00 |
| Dec 31, 2024 |
46,588.00 |
| Sep 30, 2024 |
102,821.00 |
| Jun 30, 2024 |
58,999.00 |
| Mar 31, 2024 |
89,899.00 |
| Dec 31, 2023 |
-3,741.00 |
| Jun 30, 2023 |
-170,093.00 |
| Mar 31, 2023 |
-116,513.00 |
| Dec 31, 2022 |
-45,306.00 |
| Sep 30, 2022 |
316,399.00 |
| Jun 30, 2022 |
-67,519.00 |
| Mar 31, 2022 |
-48,699.00 |
| Dec 31, 2021 |
-111,652.00 |
| Sep 30, 2021 |
170,512.00 |
| Jun 30, 2021 |
-13,793.00 |
| Mar 31, 2021 |
109,839.00 |
